NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Pfizer Quietly Kills 3 Pipeline Programs January 30, 2017 6 Promising Biopharmas With Major Catalysts in 2018 January 28, 2018 Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017
Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017
